Pharmaids Pharmaceuticals Ltd vs SUN PHARMACEUTICAL IND L

A side-by-side comparison of Pharmaids Pharmaceuticals Ltd (PHARMAID) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, SUN PHARMACEUTICAL IND L leads PHARMAID vs SUNPHARMA on 9 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth· not comparable
  • Size & financial health13

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
39.69
2.39
P/B ratio
20.07
0.00%
Dividend yield
0.84%
₹-3.06
EPS
₹47.84

Profitability

SUNPHARMA takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-26.50%
Return on equity
16.00%
-17.43%
Return on capital
21.00%
-65.55%
EBITDA margin
30.00%
-69.46%
Net margin
19.69%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y) even
10.03%
Profit CAGR (3Y) even
10.57%

Size & financial health

SUNPHARMA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹110 Cr
Market cap
₹4.56L Cr
₹19 Cr
Revenue
₹58,462 Cr
₹-14 Cr
Net profit
₹11,509 Cr
0.49
Debt / equity
0.61
Pharmaids Pharmaceuticals Ltd
  • + ["Company has reduced debt.", "Debtor days have improved from 56.1 to 44.9 days."]
  • ["Company has low interest coverage ratio.", "Promoter holding is low: 33.0%", "Company has a low return on equity of -19.4% over last 3 years."]
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
Pharmaids Pharmaceuticals Ltd full analysis SUN PHARMACEUTICAL IND L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.